openPR Logo
Press release

Disposable Insulin Pen Market – Trends,2025

02-07-2018 03:33 PM CET | Health & Medicine

Press release from: Medical Device By CMI

Insulin is a crucial compound for the management of diabetes, both type 1 and type 2; however, it is more commonly used for the management of type 2 diabetes. Insulin pen device is a fairly new innovation and was first introduced over 20 years ago. It has evolved to offer significant advantages as compared to the vial and syringe. The pens come in two forms - disposable and reusable. Disposable insulin pens contain a prefilled cartridge. The entire pen is discarded when the cartridge is vacant. On the other hand, reusable pens allow the patient to replace the cartridge when empty.

Insulin pen devices are now being used by diabetic patients across the world; nonetheless, there are geographical variations in the use of disposable and reusable pens. In some part of the world, the vial and syringe is the most popular method till now, whereas in other parts the use of disposable or reusable pens is more common. The variation in usage is due to many factors including physician/patient preference and awareness, patient access to insulin, and cost. The use of insulin in inpatient is very common, and the use of insulin pens offers substantial benefits in this type of patients, both during the admission period and after discharge from the hospital. This widespread use of insulin pens is likely to fuel the growth of the disposable insulin pen market.
Insulin pens typically deliver anywhere between .5 and 80 units of insulin at a time. The maximum dose is dependent on the patient and it varies among pens. The insulin pen a patient use depends upon the type of insulin he/she requires, the number of units needed per shot, and the availability of pens. The needles that are used in these pens vary in shapes and sizes.

Request a sample copy of this report@
https://www.coherentmarketinsights.com/insight/request-sample/497

Disposable insulin pen Market Taxonomy
On the basis of type of diabetes the global disposable insulin pen market is classified into:
Type I diabetes,Type II diabetes
On the basis of distribution, the global disposable insulin pen market is classified into:
Hospitals,Clinics,Chemists,Others
Increasing prevalence of diabetes and rising geriatric population will drive the overall disposable insulin pen market

As per International Diabetic Federation (IDF) around 415 million people suffered from diabetes in 2015. This number is likely to increase to 642 million by 2040. According to American Diabetic Association, about 29.1 million people in America had diabetes in 2012; that is a whopping 9.3% of the population. Out of this population, 21.0 million were diagnosed. As the number of patients with diabetes is poised to increase, the need for insulin is also set to rise, thereby fuelling the global disposable insulin pen market during the forecast period.

Asia Pacific, especially in countries such as India and China, the demand for disposable insulin pens is expected to gain significant traction. According to American Diabetic Association, around 60% of the world’s diabetic population lives in Asia. The prevalence of diabetes in India and China is 8.6% and 9.6% respectively. India is known as the diabetes capital of the world with more than 60 million diabetics in the country. As the number is on the rise, so is the need for disposable insulin pen. As more and more patients are diagnosed with diabetes, more and more insulin pens will be needed. Since disposable insulin pen is easier to use than the reusable variety, the global disposable insulin pen market potential is fairly high and is likely to increase in the coming years.
Chemists are the most preferred channel for players in the disposable insulin pen market. Once a patient is diagnosed with diabetes, the need for hospitalization decreases compared to insulin administration by the patient. Most patients rely on diagnostic centers for getting their tests done and are likely to obtain their insulin pens from the chemist once the test results are positive. Therefore, a patient is likely to go the chemist for obtaining these pens, thereby fuelling the growth of disposable insulin pen in the chemist shops.
Some of the companies operating in the disposable insulin pen market are Levemir, BD, Novo Nordisk, and Sanofi-Aventis.

Get More Details about this Report@
https://www.coherentmarketinsights.com/ongoing-insight/disposable-insulin-pen-market-497

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Disposable Insulin Pen Market – Trends,2025 here

News-ID: 935752 • Views: 297

More Releases from Medical Device By CMI

Custom Procedure Trays and Packs Market – Insights
Increasing number of surgical procedures is fuelling the adoption of custom procedure trays and packs (CPTP) market during the forecast period. For instance, according to the WHO, global volume of the surgeries performed in 2012 was estimated to 266.2 to 359.5 million, out of which one in every 20 operations globally was done in very-low-expenditure Member States. Increase in geriatric population, who are more likely to develop chronic wounds as they
Robotic Rehabilitation and Assistive Technologies Market, By Product Type
Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent
Spectrophotometer Market : Moving Towards a Brighter Future
North America is expected to hold dominant position in the market and is also expected to show significant growth in the spectrometer market, due to increasing launch of novel products in the region by key players. For instance, in February 2018, Thermo Fisher Scientific, a U.S.-based company, launched TSQ 9000 Triple Quadrupole GC-MS/MS System. This system has been designed to increase productivity, with enhanced sensitivity, and it also reduces maintenance
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical laboratories use automation for the management of large number of samples through, either total automation systems or high level analyzer automation that are offered by clinical mass spectrometers

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in